These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 20810784)
1. Functional interactions as a survival strategy against abnormal aggregation. Masino L; Nicastro G; Calder L; Vendruscolo M; Pastore A FASEB J; 2011 Jan; 25(1):45-54. PubMed ID: 20810784 [TBL] [Abstract][Full Text] [Related]
2. Flanking domain stability modulates the aggregation kinetics of a polyglutamine disease protein. Saunders HM; Gilis D; Rooman M; Dehouck Y; Robertson AL; Bottomley SP Protein Sci; 2011 Oct; 20(10):1675-81. PubMed ID: 21780213 [TBL] [Abstract][Full Text] [Related]
3. Characterization of the structure and the amyloidogenic properties of the Josephin domain of the polyglutamine-containing protein ataxin-3. Masino L; Nicastro G; Menon RP; Dal Piaz F; Calder L; Pastore A J Mol Biol; 2004 Dec; 344(4):1021-35. PubMed ID: 15544810 [TBL] [Abstract][Full Text] [Related]
4. Josephin domain of ataxin-3 contains two distinct ubiquitin-binding sites. Nicastro G; Masino L; Esposito V; Menon RP; De Simone A; Fraternali F; Pastore A Biopolymers; 2009 Dec; 91(12):1203-14. PubMed ID: 19382171 [TBL] [Abstract][Full Text] [Related]
5. Understanding the role of the Josephin domain in the PolyUb binding and cleavage properties of ataxin-3. Nicastro G; Todi SV; Karaca E; Bonvin AM; Paulson HL; Pastore A PLoS One; 2010 Aug; 5(8):e12430. PubMed ID: 20865150 [TBL] [Abstract][Full Text] [Related]
6. Mode of substrate recognition by the Josephin domain of ataxin-3, which has an endo-type deubiquitinase activity. Satoh T; Sumiyoshi A; Yagi-Utsumi M; Sakata E; Sasakawa H; Kurimoto E; Yamaguchi Y; Li W; Joazeiro CA; Hirokawa T; Kato K FEBS Lett; 2014 Nov; 588(23):4422-30. PubMed ID: 25448680 [TBL] [Abstract][Full Text] [Related]
10. Towards a structural understanding of the fibrillization pathway in Machado-Joseph's disease: trapping early oligomers of non-expanded ataxin-3. Gales L; Cortes L; Almeida C; Melo CV; Costa MC; Maciel P; Clarke DT; Damas AM; Macedo-Ribeiro S J Mol Biol; 2005 Oct; 353(3):642-54. PubMed ID: 16194547 [TBL] [Abstract][Full Text] [Related]
11. The Josephin domain determines the morphological and mechanical properties of ataxin-3 fibrils. Masino L; Nicastro G; De Simone A; Calder L; Molloy J; Pastore A Biophys J; 2011 Apr; 100(8):2033-42. PubMed ID: 21504740 [TBL] [Abstract][Full Text] [Related]
12. Ataxin-3 protein modification as a treatment strategy for spinocerebellar ataxia type 3: removal of the CAG containing exon. Evers MM; Tran HD; Zalachoras I; Pepers BA; Meijer OC; den Dunnen JT; van Ommen GJ; Aartsma-Rus A; van Roon-Mom WM Neurobiol Dis; 2013 Oct; 58():49-56. PubMed ID: 23659897 [TBL] [Abstract][Full Text] [Related]
13. Destabilization of non-pathological variants of ataxin-3 by metal ions results in aggregation/fibrillogenesis. Ricchelli F; Fusi P; Tortora P; Valtorta M; Riva M; Tognon G; Chieregato K; Bolognin S; Zatta P Int J Biochem Cell Biol; 2007; 39(5):966-77. PubMed ID: 17300980 [TBL] [Abstract][Full Text] [Related]
15. In vivo suppression of polyglutamine neurotoxicity by C-terminus of Hsp70-interacting protein (CHIP) supports an aggregation model of pathogenesis. Williams AJ; Knutson TM; Colomer Gould VF; Paulson HL Neurobiol Dis; 2009 Mar; 33(3):342-53. PubMed ID: 19084066 [TBL] [Abstract][Full Text] [Related]
16. Expansion of amino acid homo-sequences in proteins: insights into the role of amino acid homo-polymers and of the protein context in aggregation. Menon RP; Pastore A Cell Mol Life Sci; 2006 Jul; 63(14):1677-85. PubMed ID: 16791428 [TBL] [Abstract][Full Text] [Related]
17. Josephin domain-containing proteins from a variety of species are active de-ubiquitination enzymes. Tzvetkov N; Breuer P Biol Chem; 2007 Sep; 388(9):973-8. PubMed ID: 17696782 [TBL] [Abstract][Full Text] [Related]
18. Deubiquitinating function of ataxin-3: insights from the solution structure of the Josephin domain. Mao Y; Senic-Matuglia F; Di Fiore PP; Polo S; Hodsdon ME; De Camilli P Proc Natl Acad Sci U S A; 2005 Sep; 102(36):12700-5. PubMed ID: 16118278 [TBL] [Abstract][Full Text] [Related]
19. Polyglutamine diseases: the special case of ataxin-3 and Machado-Joseph disease. Matos CA; de Macedo-Ribeiro S; Carvalho AL Prog Neurobiol; 2011 Sep; 95(1):26-48. PubMed ID: 21740957 [TBL] [Abstract][Full Text] [Related]
20. Poly-ubiquitin binding by the polyglutamine disease protein ataxin-3 links its normal function to protein surveillance pathways. Chai Y; Berke SS; Cohen RE; Paulson HL J Biol Chem; 2004 Jan; 279(5):3605-11. PubMed ID: 14602712 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]